VISMONEO - a phase II study assessing vismodegib in the neoadjuvant treatment of locally advanced basal cell carcinoma - Patients characteristics
Gespeichert in:
| Veröffentlicht in: | Annals of oncology 2016-10, Vol.27, p.vi399-vi399 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | vi399 |
|---|---|
| container_issue | |
| container_start_page | vi399 |
| container_title | Annals of oncology |
| container_volume | 27 |
| creator | Basset-Seguin, N. Dupuy, A. Saiag, P. Dalac-Rat, S. Guillot, B. Routier, E. Leccia, M.T. Duhamel, A. Mirabel, X. Benbouta, I. Mirakovska, L. Meddour, D. Dib, M. Mahmoudi, A. Guerreschi, P. Mortier, L. |
| description | |
| doi_str_mv | 10.1093/annonc/mdw379.49 |
| format | Article |
| fullrecord | <record><control><sourceid>elsevier_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1093_annonc_mdw379_49</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0923753419447789</els_id><sourcerecordid>S0923753419447789</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3219-ae8c37081835a752f2fed90502f4bec1262acd4c4bd48b8357ce75713db91fd3</originalsourceid><addsrcrecordid>eNp1kMtOxDAMRSMEEsNjzzI_UEiadtqwQ4jHSAODBGJbuY47E9QHisMgPoM_JmjYsrEt2cf2vUKcaXWulTUXMI7TiBeD-zSVPS_snpjpcm6zWhV6X8yUzU1WlaY4FEfMb0qpuc3tTHy_Lp4fVo83K5lJkO8bYJKLheT44b4kMBOzH9dy63mYHK19K_0o44bkSBO4t48tjFHGQBAHStXUyX5C6PsEu9RDcrIFhl4i9SlAQD9OA6RrTxB9QljiBgJgpOA5euQTcdBBz3T6l4_Fy-3Ny_V9tlzdLa6vlhmaXNsMqEZTqVrXpoSqzLu8I2dVqfKuaAl1Ps8BXYFF64q6TUMVUlVW2rjW6s6ZY6F2azFMzIG65j34AcJXo1Xz62izc7TZOdoUNiGXO4TSW1tPoWFMEpJGHwhj4yb_P_wDEhCDfA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>VISMONEO - a phase II study assessing vismodegib in the neoadjuvant treatment of locally advanced basal cell carcinoma - Patients characteristics</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Basset-Seguin, N. ; Dupuy, A. ; Saiag, P. ; Dalac-Rat, S. ; Guillot, B. ; Routier, E. ; Leccia, M.T. ; Duhamel, A. ; Mirabel, X. ; Benbouta, I. ; Mirakovska, L. ; Meddour, D. ; Dib, M. ; Mahmoudi, A. ; Guerreschi, P. ; Mortier, L.</creator><creatorcontrib>Basset-Seguin, N. ; Dupuy, A. ; Saiag, P. ; Dalac-Rat, S. ; Guillot, B. ; Routier, E. ; Leccia, M.T. ; Duhamel, A. ; Mirabel, X. ; Benbouta, I. ; Mirakovska, L. ; Meddour, D. ; Dib, M. ; Mahmoudi, A. ; Guerreschi, P. ; Mortier, L.</creatorcontrib><identifier>ISSN: 0923-7534</identifier><identifier>EISSN: 1569-8041</identifier><identifier>DOI: 10.1093/annonc/mdw379.49</identifier><language>eng</language><publisher>Elsevier Ltd</publisher><ispartof>Annals of oncology, 2016-10, Vol.27, p.vi399-vi399</ispartof><rights>2016 European Society for Medical Oncology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3219-ae8c37081835a752f2fed90502f4bec1262acd4c4bd48b8357ce75713db91fd3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids></links><search><creatorcontrib>Basset-Seguin, N.</creatorcontrib><creatorcontrib>Dupuy, A.</creatorcontrib><creatorcontrib>Saiag, P.</creatorcontrib><creatorcontrib>Dalac-Rat, S.</creatorcontrib><creatorcontrib>Guillot, B.</creatorcontrib><creatorcontrib>Routier, E.</creatorcontrib><creatorcontrib>Leccia, M.T.</creatorcontrib><creatorcontrib>Duhamel, A.</creatorcontrib><creatorcontrib>Mirabel, X.</creatorcontrib><creatorcontrib>Benbouta, I.</creatorcontrib><creatorcontrib>Mirakovska, L.</creatorcontrib><creatorcontrib>Meddour, D.</creatorcontrib><creatorcontrib>Dib, M.</creatorcontrib><creatorcontrib>Mahmoudi, A.</creatorcontrib><creatorcontrib>Guerreschi, P.</creatorcontrib><creatorcontrib>Mortier, L.</creatorcontrib><title>VISMONEO - a phase II study assessing vismodegib in the neoadjuvant treatment of locally advanced basal cell carcinoma - Patients characteristics</title><title>Annals of oncology</title><issn>0923-7534</issn><issn>1569-8041</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNp1kMtOxDAMRSMEEsNjzzI_UEiadtqwQ4jHSAODBGJbuY47E9QHisMgPoM_JmjYsrEt2cf2vUKcaXWulTUXMI7TiBeD-zSVPS_snpjpcm6zWhV6X8yUzU1WlaY4FEfMb0qpuc3tTHy_Lp4fVo83K5lJkO8bYJKLheT44b4kMBOzH9dy63mYHK19K_0o44bkSBO4t48tjFHGQBAHStXUyX5C6PsEu9RDcrIFhl4i9SlAQD9OA6RrTxB9QljiBgJgpOA5euQTcdBBz3T6l4_Fy-3Ny_V9tlzdLa6vlhmaXNsMqEZTqVrXpoSqzLu8I2dVqfKuaAl1Ps8BXYFF64q6TUMVUlVW2rjW6s6ZY6F2azFMzIG65j34AcJXo1Xz62izc7TZOdoUNiGXO4TSW1tPoWFMEpJGHwhj4yb_P_wDEhCDfA</recordid><startdate>20161001</startdate><enddate>20161001</enddate><creator>Basset-Seguin, N.</creator><creator>Dupuy, A.</creator><creator>Saiag, P.</creator><creator>Dalac-Rat, S.</creator><creator>Guillot, B.</creator><creator>Routier, E.</creator><creator>Leccia, M.T.</creator><creator>Duhamel, A.</creator><creator>Mirabel, X.</creator><creator>Benbouta, I.</creator><creator>Mirakovska, L.</creator><creator>Meddour, D.</creator><creator>Dib, M.</creator><creator>Mahmoudi, A.</creator><creator>Guerreschi, P.</creator><creator>Mortier, L.</creator><general>Elsevier Ltd</general><scope>6I.</scope><scope>AAFTH</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20161001</creationdate><title>VISMONEO - a phase II study assessing vismodegib in the neoadjuvant treatment of locally advanced basal cell carcinoma - Patients characteristics</title><author>Basset-Seguin, N. ; Dupuy, A. ; Saiag, P. ; Dalac-Rat, S. ; Guillot, B. ; Routier, E. ; Leccia, M.T. ; Duhamel, A. ; Mirabel, X. ; Benbouta, I. ; Mirakovska, L. ; Meddour, D. ; Dib, M. ; Mahmoudi, A. ; Guerreschi, P. ; Mortier, L.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3219-ae8c37081835a752f2fed90502f4bec1262acd4c4bd48b8357ce75713db91fd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Basset-Seguin, N.</creatorcontrib><creatorcontrib>Dupuy, A.</creatorcontrib><creatorcontrib>Saiag, P.</creatorcontrib><creatorcontrib>Dalac-Rat, S.</creatorcontrib><creatorcontrib>Guillot, B.</creatorcontrib><creatorcontrib>Routier, E.</creatorcontrib><creatorcontrib>Leccia, M.T.</creatorcontrib><creatorcontrib>Duhamel, A.</creatorcontrib><creatorcontrib>Mirabel, X.</creatorcontrib><creatorcontrib>Benbouta, I.</creatorcontrib><creatorcontrib>Mirakovska, L.</creatorcontrib><creatorcontrib>Meddour, D.</creatorcontrib><creatorcontrib>Dib, M.</creatorcontrib><creatorcontrib>Mahmoudi, A.</creatorcontrib><creatorcontrib>Guerreschi, P.</creatorcontrib><creatorcontrib>Mortier, L.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>CrossRef</collection><jtitle>Annals of oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Basset-Seguin, N.</au><au>Dupuy, A.</au><au>Saiag, P.</au><au>Dalac-Rat, S.</au><au>Guillot, B.</au><au>Routier, E.</au><au>Leccia, M.T.</au><au>Duhamel, A.</au><au>Mirabel, X.</au><au>Benbouta, I.</au><au>Mirakovska, L.</au><au>Meddour, D.</au><au>Dib, M.</au><au>Mahmoudi, A.</au><au>Guerreschi, P.</au><au>Mortier, L.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>VISMONEO - a phase II study assessing vismodegib in the neoadjuvant treatment of locally advanced basal cell carcinoma - Patients characteristics</atitle><jtitle>Annals of oncology</jtitle><date>2016-10-01</date><risdate>2016</risdate><volume>27</volume><spage>vi399</spage><epage>vi399</epage><pages>vi399-vi399</pages><issn>0923-7534</issn><eissn>1569-8041</eissn><pub>Elsevier Ltd</pub><doi>10.1093/annonc/mdw379.49</doi><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0923-7534 |
| ispartof | Annals of oncology, 2016-10, Vol.27, p.vi399-vi399 |
| issn | 0923-7534 1569-8041 |
| language | eng |
| recordid | cdi_crossref_primary_10_1093_annonc_mdw379_49 |
| source | Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection |
| title | VISMONEO - a phase II study assessing vismodegib in the neoadjuvant treatment of locally advanced basal cell carcinoma - Patients characteristics |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T06%3A53%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=VISMONEO%20-%20a%20phase%20II%20study%20assessing%20vismodegib%20in%20the%20neoadjuvant%20treatment%20of%20locally%20advanced%20basal%20cell%20carcinoma%20-%20Patients%20characteristics&rft.jtitle=Annals%20of%20oncology&rft.au=Basset-Seguin,%20N.&rft.date=2016-10-01&rft.volume=27&rft.spage=vi399&rft.epage=vi399&rft.pages=vi399-vi399&rft.issn=0923-7534&rft.eissn=1569-8041&rft_id=info:doi/10.1093/annonc/mdw379.49&rft_dat=%3Celsevier_cross%3ES0923753419447789%3C/elsevier_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_els_id=S0923753419447789&rfr_iscdi=true |